Fig. 4
From: A central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain
Analysis of the therapeutic effects of patients with acute and subacute in ZAP. (a) Changes of VAS scores at baseline, discharge and 6 months postoperative in Non-PHN patients.Two-way analysis of variance with repeated measures and post-hocmultiple pairwise comparison Sidak’s testing was used to assess the alteration of pain scores between two groups over time.***P<0.001. (b) Numbers of Non-PHN progressing to PHN at 6 months postoperative.χ2 test, P = 0.038.
